SCHEMBL25079627

SCHEMBL25079627

O=C1CCC(c2ccc(OCC(=O)N3CCNCC3)cc2)C(=O)N1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TPSAB1 Q15661 1/20 0.57
▸ TPSD1 Q9BZJ3 1/20 0.57
▸ TPSG1 Q9NRR2 1/20 0.57
▸ CRBN Q96SW2 9/20 0.57
▸ DDB1 Q16531 8/20 0.52
▸ POLB P06746 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ LMNA P02545 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ HPGD P15428 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ ALK Q9UM73 1/20 0.41
▸ SCN7A Q01118 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30257502 0.99 TPSAB1 (0.56) TPSAB1TPSD1TPSG1CRBNDDB1
SCHEMBL24754830 0.87 CRBN (0.56) TPSAB1TPSD1TPSG1CRBNDDB1
SCHEMBL30257050 0.83 CRBN (0.59) CRBNDDB1POLBALK
SCHEMBL24548308 0.81 CRBN (0.67) CRBNDDB1POLBLMNAMAPT
SCHEMBL24491364 0.81 CRBN (0.67) CRBNDDB1POLBLMNAMAPT
SCHEMBL24754196 0.80 CRBN (0.52) CRBNDDB1POLB
SCHEMBL24548186 0.80 CRBN (0.66) CRBNDDB1POLBL3MBTL1LMNA
SCHEMBL31232873 0.79 CRBN (0.52) CRBNDDB1POLBL3MBTL1HPGD
SCHEMBL30256859 0.78 CRBN (0.56) TPSAB1TPSD1TPSG1CRBNDDB1
SCHEMBL24847990 0.78 CRBN (0.75) CRBNDDB1POLBLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023023531-A1 ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-02-23 — — WO disclosed
WO-2023023531-A1 ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-02-23 — — WO disclosed
Send feedback